| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
350,000,000 |
| Market
Cap: |
5.18(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$13.68 - $20.99 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Bausch + Lomb is an eye health company. Co. operates in three segments: Vision Care/Consumer Health Care, which includes both a contact lens business and a consumer eye care business that consists of contact lens care products, over-the-counter eye drops and eye vitamins; Ophthalmic Pharmaceuticals, which consists of a line of proprietary pharmaceutical products for post-operative treatments and treatments for a number of eye conditions, such as glaucoma, eye inflammation, dry eyes and retinal diseases; and Surgical, which consists of medical device equipment, consumables and instrumental tools and technologies for the treatment of corneal, cataracts and vitreous and retinal eye conditions.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
39,550,357 |
| Total Sell Value |
$0 |
$0 |
$0 |
$674,531,339 |
| Total People Sold |
0 |
0 |
0 |
1 |
| Total Sell Transactions |
0 |
0 |
0 |
2 |
| End Date |
2024-02-08 |
2023-11-07 |
2023-05-09 |
2022-05-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Gordon Joseph F |
Please see remarks |
• – – |
2022-05-05 |
4 |
A |
$0.00 |
$0 |
D/D |
69,444 |
69,444 |
|
- |
|
| Papa Joseph C |
CEO & Chairman |
• • – |
2022-05-05 |
4 |
A |
$0.00 |
$0 |
D/D |
472,222 |
472,222 |
|
- |
|
| Ackermann Christina |
Please see remarks |
• – – |
2022-05-05 |
4 |
A |
$0.00 |
$0 |
D/D |
83,333 |
83,333 |
|
- |
|
| Hashad Yehia |
EVP, R&D and CMO |
• – – |
2022-05-05 |
4 |
A |
$0.00 |
$0 |
D/D |
34,722 |
34,722 |
|
- |
|
| Eldessouky Sam |
Chief Financial Officer |
• – – |
2022-05-05 |
4 |
A |
$0.00 |
$0 |
D/D |
125,000 |
125,000 |
|
- |
|
| Bausch Health Companies Inc. |
10% Owner |
– – • |
2022-05-05 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
350,000,000 |
|
- |
|
81 Records found
|
|
Page 4 of 4 |
|
|
0.09 (0.6%) 
